These findings indicate that activation of the SOCS3-CDKN1A axis in SOCS1-deficient hepatocytes promotes NRF2-mediated antioxidant response that can increase tolerance to oxidative stress and tumor growth. The gene discussed is SOCS1; the disease is neoplasm.